136 related articles for article (PubMed ID: 7807163)
1. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor.
Ciardi M; Sharief MK; Thompson EJ; Salotti A; Vullo V; Sorice F; Cirelli A
J Neurol Sci; 1994 Sep; 125(2):175-9. PubMed ID: 7807163
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals. Correlation with local production of specific IgM and IgG antibodies.
Ciardi M; Sharief MK; Noori MA; Thompson EJ; Salotti A; Rossi F; Vullo V; Catania S; Sorice F; Cirelli A
J Neurol Sci; 1993 Mar; 115(1):117-22. PubMed ID: 8468587
[TBL] [Abstract][Full Text] [Related]
3. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
Herold M; Meise U; Günther V; Rössler H; Zangerle R
Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
J Neuroimmunol; 1990 Jul; 28(2):97-109. PubMed ID: 2113934
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
[TBL] [Abstract][Full Text] [Related]
7. Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.
Noronha IL; Daniel V; Schimpf K; Opelz G
Clin Exp Immunol; 1992 Feb; 87(2):287-92. PubMed ID: 1735193
[TBL] [Abstract][Full Text] [Related]
8. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
Gallo P; Piccinno MG; Pagni S; Argentiero V; Giometto B; Bozza F; Tavolato B
J Neurol Sci; 1989 Aug; 92(1):9-15. PubMed ID: 2504888
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
11. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission.
Shaw CE; Dunbar PR; Macaulay HA; Neale TJ
J Neurol; 1995 Jan; 242(2):53-8. PubMed ID: 7707089
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Weller M; Stevens A; Sommer N; Schabet M; Wiethölter H
Cancer; 1992 Mar; 69(6):1475-80. PubMed ID: 1371713
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.
Fortis C; Soldini L; Ghezzi S; Colombo S; Tambussi G; Vicenzi E; Gianotti N; Nozza S; Veglia F; Murone M; Lazzarin A; Poli G
AIDS Res Hum Retroviruses; 2002 May; 18(7):491-9. PubMed ID: 12015902
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M
Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients.
Vladić A; Horvat G; Vukadin S; Sucić Z; Simaga S
Cytokine; 2002 Oct; 20(2):86-9. PubMed ID: 12445803
[TBL] [Abstract][Full Text] [Related]
17. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation.
Deng MC; Erren M; Kammerling L; Gunther F; Kerber S; Fahrenkamp A; Assmann G; Breithardt G; Scheld HH
Transplantation; 1995 Nov; 60(10):1118-24. PubMed ID: 7482719
[TBL] [Abstract][Full Text] [Related]
18. In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.
Sharief MK; Hentges R; Ciardi M; Thompson EJ
J Neurol; 1993 Jan; 240(1):46-50. PubMed ID: 8423463
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.
Liu Y; Ho RC; Mak A
J Affect Disord; 2012 Aug; 139(3):230-9. PubMed ID: 21872339
[TBL] [Abstract][Full Text] [Related]
20. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change.
Hofmann B; Nishanian P; Fahey JL; Esmail I; Jackson AL; Detels R; Cumberland W
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):212-24. PubMed ID: 1680589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
